The intranasal infusion of MPTP or the injection of α-synuclein preformed fibrils into the duodenum enable to recapitulate some of the early-stage symptoms of PD, including non-motor signs, therefore representing relevant models for investigating prodromal PD (Table 2). The gene discussed is SNCA; the disease is Parkinson disease.